Navigation Links
Concerns Rise About New Phentermine Drug According to Houston Chronicle Report
Date:8/28/2013

Vienna, VA (PRWEB) August 28, 2013

While patients may see weight loss using new prescription drug options that contain phentermine, some risks may simply outweigh the benefits for many patients, according to a new article entitled, “Diet pills stir debate as more enter market,” from the Houston Chronicle published on August 13, 2013.

Phentermine was part of the popular diet combination pill known as fen-phen, which the article states was removed from the market in 1997 because the “fen” half of the combination, fenfluramine, was known to cause heart damage. Phentermine remained available, but was only approved for patient short-term usage due to possible side effects.

The FDA has now approved Qsymia, another combination drug that contains phentermine, though it initially rejected the drug as being unsafe last year. The article states that it is unclear what caused this about-face, though this new phentermine combination drug has been approved on the basis that long-term trials will have to be performed to determine if it is safe. Dr. John Swartzberg, a clinical professor from UC Berkeley, states in the article that he would be leery to prescribe any diet medication, including the new phentermine combo drug, to his patients that hadn't passed a “three- to five-year test” of proving that it doesn't cause any side effects in three to five years of widespread usage. It will be available to the public while these trials are being performed.

The Houston Chronicle also mentions that Consumer Reports, a trusted consumer reviewing publication, has recommended that individuals not take this new phentermine combination drug due to the risks, which include possible birth defects. Despite the fact that there are more than 78 million obese adults in the US, according to the article, concerns expressed by publications like Consumer Reports and fears of side effects lead to extremely poor sales of Qsymia, the drug containing phentermine.

The main side effects of phentermine, according to a patient who shared her story for the article, are appetite suppression and an increase in energy. These same results can be achieved with phenylethylamine HCL, the main ingredient in PhenObestin 37.5 from ShopPharmacyCounter.com. This pharmaceutical grade supplement is available without a prescription, and unlike phentermine which has not been determined safe for long term usage, PhenObestin 37.5 can be used until an individual reaches their goal or whenever one needs extra energy or help with appetite suppression. This safe alternative to phentermine, and adipex, is available today by calling 1-800-935-6312 or visiting http://www.adipexdispensary.com.

About ShopPharmacyCounter.com
Based in the suburbs of Maryland, ShopPharmacyCounter.com offers effective weight loss products while providing customers with a unique shopping experience. Their offerings strive to assist customers to lose weight as effortlessly as possible. With a commitment to quality and client satisfaction, ShopPharmacyCounter.com has helped countless individuals tackle weight related problems.

Operating as one-of-a-kind online pharmacy, their customers come from every corner of the world. Celebrating a proud legacy of a customer-base that continues to grow, ShopPharmacyCounter.com works towards ensuring health for every single client. Dealing in supplements, muscle building vitamins and a wide array of weight loss products, they never fail to meet and exceed expectations.

Read the full story at http://www.prweb.com/releases/2013/8/prweb11069724.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Concerns about MRSA for expectant mothers may be unfounded
2. Study answers Medicare concerns about paying for CT colonography
3. University of Louisville study dispels concerns about drive-thru flu clinics
4. New survey shows patient concerns and misinformation impede treatment of menopausal women
5. Climate concerns
6. Debt and income concerns deter medical students from primary care careers
7. Hair Concerns May Discourage Exercise for Some Black Women
8. US Drug Watchdog Now Urges All Recipients Of A All Metal Hip Implant to Get A Blood Test Out of New Concerns About Side Effects and They Name Law Firms To Help Victims
9. Online message boards provide outlets for mothers concerns, MU researcher says
10. Hog Ties, Duct Tape, and Airlines: Lawyers at Console & Hollawell Discuss Liability Concerns over Restraining Passengers Mid-Flight
11. Increasing concerns surrounding surrogacy
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/23/2017)... , ... March 23, 2017 , ... ... services to their communities, 16 more public health departments have been awarded national ... bring another 4.5 million people into the expanding network of communities across the ...
(Date:3/23/2017)... ... 23, 2017 , ... The IoT (Internet of Things) is revolutionizing the way ... impact on businesses and individual consumers alike. Laboratories can maximize their profit margin ... anywhere from $4 trillion to $11 trillion dollars by the year 2025. McKinsey expects ...
(Date:3/23/2017)... ... March 23, 2017 , ... ... businesses of the Norwalk and Vermillion areas, celebrates the newest charity campaign ... a nonprofit, community-based substance abuse prevention and peer recovery support organization providing ...
(Date:3/23/2017)... ... 23, 2017 , ... The StayWell Company announced today that ... covers StayWell’s asthma, coronary artery disease, congestive heart failure, chronic obstructive pulmonary disease, ... excellent programs for the delivery and improvement of disease management and that meet ...
(Date:3/23/2017)... ... March 23, 2017 , ... The TouchPoint Solution, home of Buzzies ... stress and anxiety. , “Buzzies change the way we interact with stress and ... , Since its launch date in December 2016, The TouchPoint Solution has sold more ...
Breaking Medicine News(10 mins):
(Date:3/24/2017)... , March 23, 2017  Mirabilis Medical, a ... medical technology for non-invasive surgery, announced today CE ... for treatment of uterine fibroids throughout the European ... received approval from the US Food and Drug ... Mirabilis System in the United States.  The Mirabilis ...
(Date:3/24/2017)... , March 24, 2017 ... to develop sutezolid as effective response to infectious disease ... Alliance and the Medicines Patent Pool (MPP) announced a ... antibiotic drug candidate which demonstrated encouraging results in early ... in combination with other TB drugs and follows the ...
(Date:3/23/2017)... 2017 Research and Markets has announced the ... Industry Forecast to 2025" report to their offering. ... The Global Cryostat Market ... the next decade to reach approximately $3.5 billion by 2025. ... all the given segments on global as well as regional levels ...
Breaking Medicine Technology: